Retina/Vitreous News

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Dilsher Dhoot, MD, shares 1 year results from the phase 2 ALTITUDE trial investigating RGX-314 gene therapy for the treatment of diabetic retinopathy.

FORT LAUDERDALE, Fla. — Time to surgery may not have a strong impact on pars plana vitrectomy outcomes when treating retained lens fragments after cataract surgery, according to a speaker here at the Retina World Congress.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Riad Sherif, MD, CEO of Oculis, discusses the company’s two phase 3 clinical trials for the OCS-01 eye drop.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Michael Singer, MD, discusses a study that investigated the durability of suprachoroidal triamcinolone acetonide for uveitic macular edema.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, David A. Eichenbaum, MD, discusses the design of phase 3 trials of sozinibercept for the treatment of neovascular age-related macular degeneration.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Darius M. Moshfeghi, MD, discusses a retinopathy of prematurity scoring system to screen telemedicine images.

FORT LAUDERDALE, Fla. — The metaverse can provide new opportunities for education in retina, according to a speaker at the Retina World Congress.

FORT LAUDERDALE, Fla. — A non-stick surface for instruments and cannulas inspired by nature may help reduce the risk for vitreoretinal detachment, according to a speaker at the Retina World Congress.

FORT LAUDERDALE, Fla. — Myopic traction maculopathy, or MTM, is an evolving disease that requires different management at different stages.

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Kourous A. Rezaei, MD, RWC president and co-founder, welcomes attendees to this year’s meeting.